相关实验视频

Updated: May 16, 2025

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum

Published on: December 4, 2015

状细胞疾病中的微RNA:综合性综述

Parul Gupta¹, Ravindra Kumar²

¹ICMR-National Institute of Research in Tribal Health, Jabalpur, Madhya Pradesh, India.

|April 5, 2025

概括

微RNAs (miRNAs) 通过调节炎症和胎儿血红蛋白,在状细胞疾病 (SCD) 中发挥关键作用. 了解miRNA相互作用,特别是疟疾,为SCD提供了新的治疗途径.

科学领域:

生物医学科学生物医学科学
遗传学遗传学是一个
分子生物学分子生物学

背景情况:

状细胞疾病 (SCD) 涉及慢性血液溶解,炎症和氧化应激,导致显著的发病率和死亡率.
微RNAs (miRNAs) 越来越多地被认为在SCD病理生理学中的调节作用.

研究的目的:

综合审查目前对SCD中miRNAs的理解.
探索miRNAs,SCD和疟疾恶化效应之间的相互作用.
讨论miRNAs作为SCD生物标志物和治疗点的潜力.

主要方法:

关于miRNAs和SCD的最近研究的文献综述.
分析miRNAs在SCD相关过程中的作用,例如胎儿血红蛋白的产生和炎症.
通过miRNA调节的镜头探索疟疾和SCD之间的相互作用.

主要成果:

miRNAs是关键SCD病理生理过程的关键调节者.
疟疾显著加剧了SCD的严重程度,miRNAs调解了其中一些影响.
miRNAs作为潜在的生物标志物和SCD的治疗标显示出希望.

结论:

了解miRNA在SCD中的参与,特别是关于疟疾共感染的理解,对于开发新的治疗策略至关重要.
基于miRNA的疗法有可能改善SCD的严重程度并改善患者的治疗结果.
需要进一步的研究来解决与SCD.miRNA相关的挑战和安全问题.

关键词:

胎儿的血红蛋白胎儿的血红蛋白疟疾:疟疾是一种疾病.状细胞疾病是一种状细胞疾病.血管封闭性危机血管封闭性危机这是一个小RNARNA.

更多相关视频

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...